Jubilant HollisterStier Capabilities Update August 2026: CPHI Special Edition

Navigating liquid sterile fill-finish operations requires specialized infrastructure and risk mitigation, particularly for high-value biologics and complex formulations. Modern manufacturing environments utilize advanced isolator lines equipped with 100% in-line weight checking to eliminate destructive sampling and product loss during fill processes. By deploying fully integrated, automated lyophilization systems and offering versatile pumping configurations—such as peristaltic or rotary piston pumps—facilities can precisely accommodate shear-sensitive or high-viscosity molecules. Additionally, structural redundancy via mirrored fill lines enables seamless capacity scaling from clinical development to commercial output without regulatory friction. Backed by dedicated cross-functional subject matter experts, this collaborative approach streamlines technology transfers, optimizes process parameters, and ensures robust compliance.

Discover how advanced sterile fill-finish capabilities can secure your drug product supply chain—explore the full resource today.